Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.

Saved in:
Bibliographic Details
Title: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.
Authors: Rhee JJ; Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA., Han J; Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA., Montez-Rath ME; Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA., Chertow GM; Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 (4), pp. 1273-1281. Date of Electronic Publication: 2024 Jan 08.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1463-1326
DOI:10.1111/dom.15427